Sanofi US has announced that the iBGStar Blood Glucose Monitoring System, consisting of the iBGStar blood glucose meter and iBGStar Diabetes Manager App, is commercially available in the U.S. iBGStar is an FDA approved blood glucose meter that directly connects to the iPhone and iPod touch. iBGStar is available  for purchase at Apple...

Medtronic has announced that the results of the in-clinic ASPIRE (Automation to Simulate Pancreatic Insulin REsponse) study met its efficacy endpoints and showed a 19% reduction in time spent below the low glucose threshold in patients using the MiniMed Paradigm System featuring Low Glucose Suspend automation, compared to conventional...

Life Scan has announced the voluntary recall of their OneTouch Verio IQ Meter. The reason given by LifeScan for the recall of the glucose meter is that under very specific circumstances the OneTouch Verio IQ Meter produces an error that causes the meter to turn itself off when a user attempts to access the “Results Log” to view...

Finnish diabetes technology company Mendor has announced an international partnership distribution agreement with a leading pharmaceutical company in the diabetes field, Merck Serono, covering the United Kingdom diabetes market.  Mendor’s first product, a blood glucose meter the Mendor Discreet, is a unique device that contains...

Continuous glucose monitoring systems maker DexCom, Inc. and Tandem, the developer of first ever touch-screen insulin pump, announced that they have signed a Development and Commercialization Agreement to integrate a future generation of DexCom’s continuous glucose monitoring (CGM) technology with Tandem’s t:slim(TM) Insulin...

Medtronic announced the U.S. market launch of the first-of-its-kind mySentry™ Remote Glucose Monitor, which allows a parent or caregiver to monitor from another room a patient’s MiniMed Paradigm® REAL-Time Revel™ System. The remote glucose monitor also marks the launch of a new category of Connected Care solutions that...

The U.S. Food and Drug Administration (FDA) granted PositiveID Corporation clearance for its iglucose(TM) mobile health system for diabetes management. iglucose uses mobile technology to revolutionize the way individuals with diabetes manage their condition. By seamlessly communicating glucose readings from data-capable glucometers...

A new study has found that long-term risk of an impaired glomerular filtration rate (GFR), which leads to end-stage renal disease and increases the risks of cardiovascular disease and death, was significantly lower among persons treated early in the course of type 1 diabetes with intensive diabetes therapy than among those treated...

ALR Technologies Inc received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Health-e-Connect (HeC) System for remote monitoring of patients in support of effective diabetes management programs. The 510(k) clearance enables the company to commence with the United States marketing and sales launch of its HeC...

Roche announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Accu-Chek Aviva Plus test system. The new maltose-independent test strip is designed to prevent the interference of maltose on blood sugar readings which can occur in rare cases when drugs containing or metabolizing to maltose are parenterally...